These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 34095319)

  • 21. Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes.
    Bartolini I; Risaliti M; Ringressi MN; Melli F; Nannini G; Amedei A; Muiesan P; Taddei A
    World J Gastroenterol; 2020 May; 26(20):2498-2513. PubMed ID: 32523307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Micro-inflammation and digestive bacterial translocation in chronic kidney disease].
    Olivier V; Dunyach-Remy C; Lavigne JP; Moranne O
    Nephrol Ther; 2018 May; 14(3):135-141. PubMed ID: 29295767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
    Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management.
    Lee TH; Chen JJ; Wu CY; Lin TY; Hung SC; Yang HY
    Biomed J; 2024 Apr; 47(2):100638. PubMed ID: 37524304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
    Guo XY; Liu XJ; Hao JY
    J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.
    Xu H; Zhao H; Fan D; Liu M; Cao J; Xia Y; Ju D; Xiao C; Guan Q
    Mediators Inflamm; 2020; 2020():1430605. PubMed ID: 32963490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies.
    Pan Q; Guo F; Huang Y; Li A; Chen S; Chen J; Liu HF; Pan Q
    Front Immunol; 2021; 12():799788. PubMed ID: 34925385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.
    Tajik N; Frech M; Schulz O; Schälter F; Lucas S; Azizov V; Dürholz K; Steffen F; Omata Y; Rings A; Bertog M; Rizzo A; Iljazovic A; Basic M; Kleyer A; Culemann S; Krönke G; Luo Y; Überla K; Gaipl US; Frey B; Strowig T; Sarter K; Bischoff SC; Wirtz S; Cañete JD; Ciccia F; Schett G; Zaiss MM
    Nat Commun; 2020 Apr; 11(1):1995. PubMed ID: 32332732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis.
    Brandl C; Bucci L; Schett G; Zaiss MM
    Eur J Immunol; 2021 Apr; 51(4):798-810. PubMed ID: 33594693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.
    Kinashi Y; Hase K
    Front Immunol; 2021; 12():673708. PubMed ID: 33968085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between gut microbiota and host immune system and its response to traumatic injury.
    Ullah H; Arbab S; Tian Y; Chen Y; Liu CQ; Li Q; Li K
    Front Immunol; 2024; 15():1413485. PubMed ID: 39144142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.
    Fan Y; Wang Y; Xiao H; Sun H
    BMC Nephrol; 2024 Jun; 25(1):203. PubMed ID: 38907188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.